In This Issue
International Association for the Study of Lung Cancer (IASLC)
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer
Early Stage Lung Cancer
Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee
Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer
Multicenter ALK Testing in Non–Small-Cell Lung Cancer
ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients
Predicting Lung Cancer Prior to Surgical Resection in Patients with Lung Nodules
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma
A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis
KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma
Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non–Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib
A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer
Impact of Non–Small-Cell Lung Cancer-Not Otherwise Specified Immunophenotyping on Treatment Outcome
Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases
Prospective Exploratory Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy with High-Dose Heart Exposure
A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction
Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients
Development of the International Thymic Malignancy Interest Group International Database
Bronchoscopic Delivery of Lipiodol as a Fiducial Marker in Lung Tumors Before Radiotherapy
Iris Metastasis from Small-Cell Lung Cancer
Clinical and in vivo Evidence that EGFR S768I Mutant Lung Adenocarcinomas Are Sensitive to Erlotinib
Rare EGFR Exon 20 S768I Mutation Predicts Resistance to Targeted Therapy
Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer
Two Cases of Non–Small-Cell Lung Cancer with Rare Complex Mutation of EGFR Exon 18 But Different Response to Targeted Therapy